Latest News and Press Releases

CryoSave in its joint venture with Ecsponent (ECS) at equal participation have sold 100% of their stake for ZAR 50,000,000 (Fifty Million South African Rand). As a leading stem cells bank,...

Amsterdam, The Netherlands - 28 June 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today a 20th Tranche of EUR 400,000 is issued as a private placement of 40...

Total investment can reach EUR 7.25 million upon exercise of share subscription warrants Amsterdam, The Netherlands - 19 June 2018 Transaction highlights Potential financing of up to EUR 5...

Amsterdam, The Netherlands - 18 June 2018 Esperite regrets to announce that due remaining technical issues as reported before and despite the constant efforts provided by the different teams...

Amsterdam, The Netherlands - 12 June 2018 Esperite N.V. (Euronext: ESP, "Esperite" or the "Group") announces today the issuance to European Select Growth Opportunities Fund (the "Investor" or...

AGAATA delivers clinical reports in the fields of Reproductive Health, Oncology and Inherited Diseases. Amsterdam, The Netherlands -6th June 2018 AGAATA innovates a fully integrated and certified...

Amsterdam, The Netherlands - 05 June 2018 Esperite regrets to announce that due to the technical issues as reported on 30 April and despite the constant efforts provided by the different teams...

Amsterdam, The Netherlands -17th May 2018 Esperite's The Cell Factory has signed today the agreement with PHARM, the Italian CRO company which is preparing for the first-in-man clinical trials...

Amsterdam, The Netherlands - 17  May 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 18th Tranche of EUR 400,000 is issued as a private placement of 40...

Amsterdam, the Netherlands - 16 May 2018 Esperite NV, The Regenerative and predictive medicine company has acquired control of its long-term South African joint venture CryoSave South Africa Ltd....